Your browser doesn't support javascript.
loading
A Systematic Review of Ebstein's Anomaly with Left Ventricular Noncompaction.
Thareja, Suma K; Frommelt, Michele A; Lincoln, Joy; Lough, John W; Mitchell, Michael E; Tomita-Mitchell, Aoy.
Afiliação
  • Thareja SK; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Frommelt MA; Department of Surgery, Division of Congenital Heart Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Lincoln J; Department of Pediatrics, Division of Pediatric Cardiology, Children's Wisconsin, Milwaukee, WI 53226, USA.
  • Lough JW; Herma Heart Institute, Children's Wisconsin, Milwaukee, WI 53226, USA.
  • Mitchell ME; Department of Pediatrics, Division of Pediatric Cardiology, Children's Wisconsin, Milwaukee, WI 53226, USA.
  • Tomita-Mitchell A; Herma Heart Institute, Children's Wisconsin, Milwaukee, WI 53226, USA.
J Cardiovasc Dev Dis ; 9(4)2022 Apr 13.
Article em En | MEDLINE | ID: mdl-35448091
ABSTRACT
Traditional definitions of Ebstein's anomaly (EA) and left ventricular noncompaction (LVNC), two rare congenital heart defects (CHDs), confine disease to either the right or left heart, respectively. Around 15-29% of patients with EA, which has a prevalence of 1 in 20,000 live births, commonly manifest with LVNC. While individual EA or LVNC literature is extensive, relatively little discussion is devoted to the joint appearance of EA and LVNC (EA/LVNC), which poses a higher risk of poor clinical outcomes. We queried PubMed, Medline, and Web of Science for all peer-reviewed publications from inception to February 2022 that discuss EA/LVNC and found 58 unique articles written in English. Here, we summarize and extrapolate commonalities in clinical and genetic understanding of EA/LVNC to date. We additionally postulate involvement of shared developmental pathways that may lead to this combined disease. Anatomical variation in EA/LVNC encompasses characteristics of both CHDs, including tricuspid valve displacement, right heart dilatation, and left ventricular trabeculation, and dictates clinical presentation in both age and severity. Disease treatment is non-specific, ranging from symptomatic management to invasive surgery. Apart from a few variant associations, mainly in sarcomeric genes MYH7 and TPM1, the genetic etiology and pathogenesis of EA/LVNC remain largely unknown.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Revista: J Cardiovasc Dev Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Systematic_reviews Idioma: En Revista: J Cardiovasc Dev Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos